US 11674139
Oligonucleotides for treating expanded repeat diseases
granted A61PA61P21/02A61P21/04
Quick answer
US patent 11674139 (Oligonucleotides for treating expanded repeat diseases) held by Sarepta Therapeutics, Inc. expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P21/02, A61P21/04, A61P25/14, A61P25/28